INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2010
|
Total net assets |
£103.1m |
|
NAV per share |
173.2p |
|
Share price |
146.3p |
|
Total value of unquoted investments |
£23.1m |
|
Total number of portfolio companies |
60 |
|
Cash |
0% NAV |
|
Cash committed and reserved to unquoted investments |
9% NAV |
|
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
5.54 |
|
Amgen |
5.29 |
|
Micromet |
5.26 |
|
Shire Ltd |
5.11 |
|
Gilead Sciences |
4.60 |
|
Insulet |
3.71 |
|
Alexion Pharmaceuticals |
3.56 |
|
Teva |
3.43 |
|
Genzyme |
3.13 |
|
Cadent |
3.12 |
|
|
----------- |
|
Total |
42.75 |
|
Geographical Allocation |
% |
|
United States |
74 |
|
Europe |
24 |
|
Australia |
2 |
|
Cash |
0 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
78 |
|
Unquoted |
22 |
|
Cash |
0 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 JANUARY 2011